“Herpes Vaccine Study Finds Few Takers at the U.”

Return to Vaccination News Home Page __» Right-click to "open in new window"

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

——————————————————————————————

Researchers at 17 clinical sites are testing an experimental herpes vaccine and are seeking 7,550 women to participate, but at the University of Utah site, enrollment has been low. Out of an anticipated 500 participants, only 24 people have volunteered for the study since January. There may be a misperception that the volunteers will contract the herpes virus, but the study’s principal investigator, Dr. Woody Spruance, states that “the patients do not get herpes” from the vaccine. Researchers test the vaccine, which is intended to protect against type 1 and type 2 herpes, by looking for antibodies in the blood of those vaccinated. The study is being led by the National Institute of Allergy and Infectious Diseases, in partnership with GlaxoSmithKline Biologicals, which would produce the vaccine.

Return to Vaccination News Home Page __» Right-click to "open in new window"

DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.